ViraClear EPS 7630

Shortens duration & reduces severity

•    Cough
•    Congestion
•    Sore Throat

Clinically studied for the common cold, bronchitis, sinusitis, and tonsillitis
•    A randomized, placebo-controlled study of 103 patients with the common cold used a liquid extract of Pelargonium sidoides. After 10 days, 78.8% of the EPs group were “clinically cured” compared to 31.4% in the placebo group.¹
•    In one multicenter study, the EPs 7630 group recovered from acute bronchitis nearly twice as fast as placebo.²
•    In another study involving children and adolescents with acute bronchitis, use of EPs 7630 resulted in nearly three times the improvement in symptoms versus placebo on day seven.³
•    In a randomized, double-blind, placebo-controlled trial, 143 children ages 6-10 years with tonsillitis received either EPs 7630 or a placebo for 6 days. By day 6, the number of children returning to school was 80.8% in the EPs 7630 group compared to only 21.4% in the placebo group.⁴

Exclusive, unique ingredient

ViraClear EPs 7630 is a homeopathic remedy containing a proprietary extract—EPs 7630—obtained from the roots of the South African Pelargonium sidoides plant.

Proven safety - over 20 clinical trials

•    An excellent remedy for the entire family
•    Studied in more than 9,000 patients, including 3,900 children
•    Proven safety in adults and children ages 2 and up

1. Lizogub VG, Riley DS, Heger M. Efficacy of a Pelargonium sidoides preparation in patients with the common cold: A randomized, double blind, placebo-controlled clinical trial. Explore 2007;3:573–84.
2. Chuchalin AG, et al. Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial. Explore 2005:1:437-445.
3. Kamin W. Pelargonium sidoides extract EPs 7630 in the treatment of respiratory tract infections in children and adults - an overview of recent results. Planta Med 2007;73:822.
4. Bereznoy V, Riley D, Wassmer G, Heger M. Efficacy of extract of Pelargonium sidoides in children with acute non-group a beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial. Altern Ther Health Med 2003;9:68–79.